SAN FRANCISCO, CA, August 09, 2010 (Press-News.org) Lampire Biological Laboratories (LBL) announced today that it signed an agreement with Proliant Health and Biologicals (Proliant), manufacturer of the worlds most trusted, high quality Bovine Serum Albumin (BSA), to do contract filling & provide BSA to customers requiring less than Proliant's standard 10 kilogram packaging. Lampire will also offer made-to-order aqueous blends in buffers and package sizes to customer specifications.
Stephen Welch, President & CEO of Proliant, said, "Proliant has become the pre-eminent bulk manufacturer of BSA, currently supplying over half of global demand. As part of this rapid growth, Proliant is committed to supplying customers who require smaller quantities of BSA the same value large scale customers enjoy, plus a greater degree of flexibility and customer service." Stephen went on to say, "The search is now over; Lampire with its contract manufacturing abilities, plus an extensive knowledge of the diagnostic and pharmaceutical industries, fulfills every attribute Proliant requires."
According to Gregory F. Krug, President & CEO of LBL, "The applications for BSA are truly endless and we are proud to enter into this strategic partnership with Proliant." Greg went on to say, "...we are looking at drug development labs, academic research institutes, biotech companies and antibody suppliers all of which need high quality BSA. The Lampire Business Model will allow us to provide them with high quality BSA in a variety of forms and formulations in a most cost-effective manner."
About Lampire Biological Laboratories
Lampire Biological Laboratories specializes in polyclonal and monoclonal antibody development, cell culture devices and services, and a wide variety of blood-derived products. Founded in 1977, the Pennsylvania based company offers an extensive line of secondary antibodies, purified IgGs, human and animal blood products, plus a comprehensive line of animal tissues and organs. The latest product and service releases include novel teratogenicity screening assays, New Zealand sourced animal blood products, the gas-permeable LAMPIRE OMNI C3 Cell Culture Bag, exclusive antibodies to chemotherapeutic agents, and Proliant BSA. Additional services include peptide synthesis, antigen design, antibody purification, custom conjugation, immunoassay development, and contract manufacturing. Lampire is a privately held company.
About Proliant Health and Biologicals
Proliant, a privately held company, is the world's largest producer of bovine plasma derivatives, such as BSA. Derived from the plasma of healthy, US-origin animals with complete traceability, Proliant's bovine serum albumin exceeds 99% purity and is suitable for diagnostic, pharmaceutical, veterinary, and research applications.
Proliant Health and Biologicals specializes in the development of ingredients from natural sources for the human health and nutrition industry, including the dietary supplement, clinical nutrition, consumer health and functional food markets. Proliant has developed exciting new technologies to isolate bio-active proteins and peptides that play vital roles in human health. The most well-known of these are immunoglobulins.
Proliant ingredients are unsurpassed in innovation and quality, which allows them to be used in the most sensitive nutritional applications. ImmunoLin is an immunoglobulin protein isolate which can be used for tablets, capsules, drink mixes, lozenges and bars.
Contacts:
Lampire Biological Laboratories
Gregory F. Krug
President
Office: 215-795-2838
Website: http://www.proliantinc.com
or
Proliant Health & Biologicals
Jim Torvik
Director of Sales and Marketing
Office: 515-289-5142
Mobile: 515-494-0700
Two Industry Leaders - Proliant Health and Biologicals and Lampire Biological Laboratories - Form Strategic Partnership to Provide Bovine Serum Albumin
This partnership will meet market needs with quality, value and flexibility.
2010-08-09
ELSE PRESS RELEASES FROM THIS DATE:
Whataburger Asks Customers: "Tell Us Why You're Our Biggest Fan!"
2010-08-09
Southern burger icon Whataburger celebrates its 60th anniversary with its "Tell Us Why You're Our Biggest Fan" online contest. At stake is a Whataburger fan's dream come true: 60 years of free Whataburger, a trip to the Whataburger convention in Dallas, TX and other cool prizes!
Beginning August 4 and all throughout the company's anniversary month of August, fans can submit either videos or essays with photos at www.whataburger.com, demonstrating why they are Whataburger's biggest fans. The first 60 fans to enter will win a coupon for a free Whataburger.
The contest ...
LAST 30 PRESS RELEASES:
Wood burning in homes drives dangerous air pollution in winter
The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: January 23, 2026
ISSCR statement in response to new NIH policy on research using human fetal tissue (Notice NOT-OD-26-028)
Biologists and engineers follow goopy clues to plant-wilting bacteria
What do rats remember? IU research pushes the boundaries on what animal models can tell us about human memory
Frontiers Science House: did you miss it? Fresh stories from Davos – end of week wrap
Watching forests grow from space
New grounded theory reveals why hybrid delivery systems work the way they do
CDI scientist joins NIH group to improve post-stem cell transplant patient evaluation
Uncovering cancer's hidden oncRNA signatures: From discovery to liquid biopsy
Multiple maternal chronic conditions and risk of severe neonatal morbidity and mortality
Interactive virtual assistant for health promotion among older adults with type 2 diabetes
Ion accumulation in liquid–liquid phase separation regulates biomolecule localization
Hemispheric asymmetry in the genetic overlap between schizophrenia and white matter microstructure
Research Article | Evaluation of ten satellite-based and reanalysis precipitation datasets on a daily basis for Czechia (2001–2021)
Nano-immunotherapy synergizing ferroptosis and STING activation in metastatic bladder cancer
Insilico Medicine receives IND approval from FDA for ISM8969, an AI-empowered potential best-in-class NLRP3 inhibitor
Combined aerobic-resistance exercise: Dual efficacy and efficiency for hepatic steatosis
Expert consensus outlines a standardized framework to evaluate clinical large language models
Bioengineered tissue as a revolutionary treatment for secondary lymphedema
Forty years of tracking trees reveals how global change is impacting Amazon and Andean Forest diversity
Breathing disruptions during sleep widespread in newborns with severe spina bifida
Whales may divide resources to co-exist under pressures from climate change
Why wetland restoration needs citizens on the ground
Sharktober: Study links October shark bite spike to tiger shark reproduction
PPPL launches STELLAR-AI platform to accelerate fusion energy research
Breakthrough in development of reliable satellite-based positioning for dense urban areas
DNA-templated method opens new frontiers in synthesizing amorphous silver nanostructures
Stress-testing AI vision systems: Rethinking how adversarial images are generated
Why a crowded office can be the loneliest place on earth
[Press-News.org] Two Industry Leaders - Proliant Health and Biologicals and Lampire Biological Laboratories - Form Strategic Partnership to Provide Bovine Serum AlbuminThis partnership will meet market needs with quality, value and flexibility.

